Therefore, theoretically, PRMT1 can be targeted either to prevent cancer cell dissemination to develop metastatic lesions, or to eradicate existing metastatic cancer cells by induction of senescence. The gene discussed is PRMT1; the disease is metastatic malignant neoplasm.